Novel Plasmapheresis Platform Increases Plasma Collection
|
By HospiMedica International staff writers Posted on 15 Oct 2020 |
|
Image: The NexSys PCS with Persona technology customizes plasma collection (Photo courtesy of Haemonetics)
A new nomogram that takes into account individual donor characteristics customizes and increases potential plasma collection.
The Haemonetics (Braintree, MA, USA) NexSys PCS plasma collection system with Persona is an automated cell separator and blood component collector device that is used to collect plasma products using single-use sterile disposable sets, with or without saline compensation. The Persona Nomogram is a novel, personalized percent plasma calculator based on body mass index (BMI) and hematocrit, enabling a more tailored collection target that allows an overall average increase of 9-12% in plasma volume collected per donation.
The open architecture of the NexSys PCS system facilitates bi-directional connectivity to the NexLynk donor management system, which enables automated collection programming and automated end of procedure documentation. A simple, intuitive guided operation, large touch screen, and on-screen troubleshooting assistance are designed to improve plasma center efficiencies, resulting in reduced total time for donors in the center and improved collection capacity per plasma center. Products that can be collected using the NexSys PCS system include source plasma and plasma for transfusion.
“Plasma is an essential component used to make life-saving and life-improving medicines for many conditions, and the current nomogram has been a safe and effective method for collecting plasma for decades,” said Jan Hartmann, MD, Vice President of medical affairs, clinical development and medical safety at Haemonetics. “Persona now sets a new paradigm by leveraging improved technology and taking a personalized approach to optimize plasma collection for each individual donor.”
During plasmapheresis, plasma is removed from the blood by a cell separator. After separation, red blood cells (RBCs) are returned to the donor, while the plasma is collected and frozen for preservation and eventual transfusion, or as an ingredient in the manufacture of a plasma-derived medicines to treat a multitude of conditions, such as primary immunodeficiency, hemophilia, convalescing COVID-19 patients, and others. The amount of plasma a donor can donate is currently based on a nomogram that is solely correlated to an individual's weight.
The Haemonetics (Braintree, MA, USA) NexSys PCS plasma collection system with Persona is an automated cell separator and blood component collector device that is used to collect plasma products using single-use sterile disposable sets, with or without saline compensation. The Persona Nomogram is a novel, personalized percent plasma calculator based on body mass index (BMI) and hematocrit, enabling a more tailored collection target that allows an overall average increase of 9-12% in plasma volume collected per donation.
The open architecture of the NexSys PCS system facilitates bi-directional connectivity to the NexLynk donor management system, which enables automated collection programming and automated end of procedure documentation. A simple, intuitive guided operation, large touch screen, and on-screen troubleshooting assistance are designed to improve plasma center efficiencies, resulting in reduced total time for donors in the center and improved collection capacity per plasma center. Products that can be collected using the NexSys PCS system include source plasma and plasma for transfusion.
“Plasma is an essential component used to make life-saving and life-improving medicines for many conditions, and the current nomogram has been a safe and effective method for collecting plasma for decades,” said Jan Hartmann, MD, Vice President of medical affairs, clinical development and medical safety at Haemonetics. “Persona now sets a new paradigm by leveraging improved technology and taking a personalized approach to optimize plasma collection for each individual donor.”
During plasmapheresis, plasma is removed from the blood by a cell separator. After separation, red blood cells (RBCs) are returned to the donor, while the plasma is collected and frozen for preservation and eventual transfusion, or as an ingredient in the manufacture of a plasma-derived medicines to treat a multitude of conditions, such as primary immunodeficiency, hemophilia, convalescing COVID-19 patients, and others. The amount of plasma a donor can donate is currently based on a nomogram that is solely correlated to an individual's weight.
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Fetal Monitor
BT-380
New
Radiofrequency Generator
GX1
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
